Navigation Links
FDA Approves EDARBI (azilsartan medoxomil) for the Treatment of Hypertension
Date:2/25/2011

DEERFIELD, Ill. and OSAKA, Japan, Feb. 25, 2011 /PRNewswire/ -- Takeda Pharmaceutical Company Limited (Takeda) and its wholly-owned subsidiary, Takeda Pharmaceuticals North America, Inc., today announced that the U.S. Food and Drug Administration (FDA) approved EDARBI (azilsartan medoxomil) for the treatment of hypertension, or high blood pressure, in adults. EDARBI is an angiotensin II receptor blocker (ARB) that lowers blood pressure by blocking the action of angiotensin II, a vasopressor hormone that constricts blood vessels. When the angiotensin II receptor is blocked, blood vessels stay relaxed and open and blood pressure can be reduced. EDARBI is approved as a once-daily oral therapy for use alone and for use in combination with other antihypertensive medications.

Takeda Global Research & Development Center, Inc. U.S. submitted a new drug application (NDA) for EDARBI in April 2010. The NDA was supported by seven controlled phase 3 clinical trials involving more than 5,900 patients with hypertension. Pivotal phase 3 studies showed EDARBI (80 mg/day) was statistically superior to placebo and the highest approved doses of two commonly prescribed ARBs, olmesartan medoxomil (40 mg/day) and valsartan (320 mg/day), in lowering both clinic and 24-hour mean blood pressure measurements.

"We are pleased to be able to build upon our global expertise in the cardiovascular therapeutic area with the approval of EDARBI in the U.S.," said Shinji Honda, president and CEO, Takeda Pharmaceuticals North America. "Through the discovery, development and commercialization of new medicines, Takeda is committed to bringing therapies like EDARBI to market. EDARBI is an important new treatment option for patients with hypertension and the health care professionals who treat them."

The safety and efficacy of EDARBI were studied as a once-daily oral therapy, as well as in combination with chlorthalidone and amlodipine. Results from the phase 3 clinical trials sh
'/>"/>

SOURCE Takeda Pharmaceuticals North America, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Product to Prevent Bleeding in People With Rare Genetic Defect
2. FDA Approves First 3-D Mammography Imaging System
3. FDA Approves 1st Pacemaker Designed to Work Safely During Some MRI Exams
4. FDA Approves Hologics Makena™ (Formerly Referred to as Gestiva™) Pharmaceutical
5. FDA Approves Drug to Reduce Risk of Preterm Birth in At-Risk Pregnant Women
6. FDA Approves Makena™, the First and Only Treatment to Reduce the Risk of Preterm Birth in Women With a Singleton Pregnancy Who Have a History of Singleton Spontaneous Preterm Birth
7. FDA Approves Viibryd to Treat Major Depressive Disorder
8. FDA Approves Head Lice Treatment for Children and Adults
9. FDA Approves Opioid Analgesic to Help Cancer Patients Manage Pain
10. VIDEO from Endo Pharmaceuticals Available on thenewsmarket.com: FDA Approves New Treatment for Low Testosterone
11. FDA Approves New Dosage Strength for INTELENCE®
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... N.H. , March 2, 2015 /PRNewswire/ ... provider of professional-grade vitamins, supplements, prescription products ... announced a strategic partnership with Anabolic Laboratories, ... for healthcare professionals. This new partnership will ... into new licensed healthcare practitioner segments and ...
(Date:3/2/2015)... 2015  Compass Diversified Holdings (NYSE: CODI ... of leading middle market businesses, announced today its consolidated ... December 31, 2014. Fourth Quarter 2014 Highlights ... Reinvestment ("CAD" or "Cash Flow") of $17.5 million for ... the full year 2014;  , Reported net income ...
(Date:3/2/2015)... 2015  DURECT Corporation (Nasdaq: DRRX ... the successful completion of a Phase 1 clinical ... DUR-928 is an endogenous, small-molecule, new chemical entity ... diseases such as nonalcoholic fatty liver disease (NAFLD) ... injuries such as acute kidney injury (AKI).        ...
Breaking Medicine Technology:Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 2Anabolic Laboratories Selects Emerson Ecologics As Distribution Partner 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 2Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 3Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 4Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 5Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 6Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 7Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 8Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 9Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 10Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 11Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 12Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 13Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 14Compass Diversified Holdings Reports Fourth Quarter and Full Year 2014 Financial Results 15DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 2DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 3DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 4DURECT Announces Epigenomic Regulator Program including a New NAFLD/NASH and Acute Organ Injury Product Candidate in Development 5
... 2012 The use of an armband-based body monitoring ... approaches to weight loss examined by researchers in an ... of Sports Medicine,s 59th Annual Meeting and 3rd ... in San Francisco. The study, "An Economic Analysis of ...
... 30, 2012 Accuray Incorporated (Nasdaq: ARAY ), ... is scheduled to present at the Jefferies Global Healthcare Conference ... a.m. EDT/8:30 a.m. PDT.  A live webcast ... Relations page of the Company,s website at http://www.accuray.com .  ...
Cached Medicine Technology:Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 2Body Monitors Deliver Better Weight Loss Results at Half the Cost: Study to Be Presented at ACSM Meeting 3
(Date:3/2/2015)... York (PRWEB) March 02, 2015 Tyrone ... Idoll Magazine, a medium for the model agency industry, ... find, and buy Mango, Passion Fruit, Pink Grapefruit, Pomegranate, ... 3rd, 2015, after 1pm. , At a cost of ... recently came under fire by announcing the brands commitment ...
(Date:3/2/2015)... Robins & Morton Celebrates Women In ... in Construction Week (March 1-7, sponsored by the National ... Women’s History Month, Robins & Morton is recognizing several ... and the construction industry as a whole. From the ... of roles in between, each woman has a story ...
(Date:3/2/2015)... Va. (PRWEB) March 02, 2015 The ... nonprofit authority on the use of health IT to ... white paper, “ICD-10 Testing for Small Providers.” The white ... with a starting point for ICD-10 testing by focusing ... payers to ensure compliance with the October 1, 2015 ...
(Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual awareness ... people across the country to unite, raise awareness, ... their best lives. MS Awareness Week is a special week ... the Society’s vision of a world free of MS. ... the central nervous system, interrupts the flow of information within ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the island’s only ... having officially opened its doors on March 2, 1990. ... 70 employees who started on Day 1 and continue to ... original employees. The celebration will be a private luau ... This Four Seasons flagship resort, the first resort in the ...
Breaking Medicine News(10 mins):Health News:Sex Sells! A Newly Minted Organic Bodycare Brand Courts Controversy at a Cost 2Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2
... West ... , ... 2010 -- According to attorney Jan Dils , Vietnam veterans who have developed diseases ... time obtaining disability benefits under a recently proposed change in veterans benefits. , , ...
... ... curriculum. Not only will large families drastically reduce waste, but parents will also be ... ... “going green” is the catch phrase of recent years. But unlike most catch phrases ...
... of asthma by age 11, study found , FRIDAY, April 23 ... -- at 25 weeks of pregnancy or earlier -- may experience ... at full-term to be diagnosed with asthma by the time they ... authors examined a database of all babies born at or before ...
... CNM, MS, FACNM has focused her 30-year career on improving ... particular focus on expanding access to nurse-midwifery care. In recognition ... others, and to the nursing community, Williams has been selected ... College of Nursing. She will be recognized for the honor ...
... ... Enhance and Restore Their Appearance, and Turn Back the Hands of Time , ... Los Angeles, Calif. (PRWEB) ... without surgery, Epione recommends Coolaser™, Radiesse® injections and other dermal fillers to achieve a ...
... abnormalities present at birth are the leading source of ... a million children in the United States have structural ... such as small holes between chambers of the heart, ... or more chambers or valves. The April issue ...
Cached Medicine News:Health News:New Disability Benefits Could Soon Be Available to Vietnam Vets 2Health News:New Disability Benefits Could Soon Be Available to Vietnam Vets 3Health News:Go Green With Your Curriculum by Choosing A Paperless Option 2Health News:Go Green With Your Curriculum by Choosing A Paperless Option 3Health News:Go Green With Your Curriculum by Choosing A Paperless Option 4Health News:Premature Birth Ups Risk of Long-Term Breathing Problems 2Health News:Nurse midwifery leader 2010 recipient of U. College of Nursing Distinguished Alumni Award 2Health News:50+ and Fabulous: Three Non-Surgical Procedures Effectively Reverse the Signs of Aging 2Health News:50+ and Fabulous: Three Non-Surgical Procedures Effectively Reverse the Signs of Aging 3Health News:New strategies to improve treatment and avert heart failure in children 2Health News:New strategies to improve treatment and avert heart failure in children 3
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
Aplicare's Prep Pads offer convenience, low cost, ease of use. The medium size is appropriate for most applications. Each package is terminally sterilized, ensuring the safest possible product for th...
IV Prep Swab Sticks are effective, easy to apply, dries quickly and reduces bacterial contaminations. They are ideal for preparation of the skin prior to a ventipuncture or injection....
... Plus PVP-I Scrub swabsticks is ... cleanser containing to prevent dryness. ... solution equivalent to 0.75% available ... kill skin surface pathogens, including ...
Medicine Products: